Broadened scope of pharmacists unlawful, unfair and not in patients’ best interests – SAMA
Proposed changes to the Pharmacy Guidelines, which will broaden the scope of practice of pharmacists, are unlawful, will compromise patient care. It present a clear conflict of interest in terms of diagnosis and treating patients, and the issuing of medicines and health products. The South African Medical Association (SAMA) has opposed the proposed amendments in a written submission to the South African Pharmacy Council (SAPC) in which it underscores its deep dismay at what it deems an over-reach of pharmacists’ roles in broadening their scope.
The proposed changes allow pharmacists to provide therapeutic guidance, and give diagnoses, and prescribe medication to patients. Pharmacists are not educated, trained or experienced in treating patients, and their focus is on medicines only. Diagnosis and treatment choices are within the domain of healthcare professionals registered as such.
In its submission SAMA notes that the rules broadening the scope of pharmacists contravenes the Health Professions Act which makes it an offence to conduct acts described under any of the professions within its ambit whilst not being registered in that specific profession.
Whilst the financial pressure pharmacies have been under since the regulation of medicines prices and their dispensing fees are understood, this reduction in income cannot be address by venturing in the scope of practice of other healthcare professionals.
In addition, the SAMA submission refers to the skills – or lack thereof – of pharmacists in performing a broadened scope of practice, which includes aspects of mental health (counselling in cases of for example gender-based violence), complex medical- and social fields such as infertility, amongst others.
“There is no way a pharmacist, by means of some ‘accredited course’ or CPD event, will be able to acquire the skills needed for diagnosis and treatment in the fields of reproductive and sexual health listed by the notice. What is being proposed, quite simply, falls far outside the scope of pharmacy and squarely within the scope of general and certain specialist medical practices” says Dr Angelique Coetzee, Chairperson of SAMA.
Also of concern to SAMA are the rights of patients who have an expectation to be treated by persons who are adequately qualified and experienced. Medical practitioners spend years in hands-on care for patients, from their third year in medical school, two years of formal internships, and gain additional experience during community service.
“It is also unclear how matters of medical negligence will be handled – are providers of pharmacist malpractice aware of this broadened scope of their clients and the implications thereof? And, what happens in cases of misdiagnosis, or the provision of incorrect treatment, care or non-referral?” asks Dr Coetzee.
Apart from these concerns, SAMA has also raised the issue of conflict of interest. A key principle of the relationship between prescribers (doctors) and dispensers (pharmacists) is that there should be no incentive to prescribe or dispense any product. It is for these reasons that medical practitioners are prohibited from owning any direct or indirect stake in any pharmacy.
“The broadening of the scope of pharmacists includes the use of any product which can have a direct benefit to a pharmacy. In our view this creates a clear incentive to over-supply, over-service or inappropriately service patients and is a massive conflict of interest. As medical professionals with patient care as our main priority, we cannot abide by such a suggestion,” notes Dr Coetzee.
Part of SAMA’s submission also focuses on the issue of unfair competition.
“Put bluntly: allowing pharmacists to compete with general practitioners and others, whilst not having the necessary qualifications, experience and registration – presumably at much lower rates – can only be described as unfair competition,” says Dr Coetzee.
SAMA says it will pursue meetings with all relevant stakeholders – including the SA Pharmacy Council and the National Department of Health, in order to protect the public.
|